Related references
Note: Only part of the references are listed.Tardive Dyskinesia and Other Movement Disorders Secondary to Aripiprazole
Maria Sierra Pena et al.
MOVEMENT DISORDERS (2011)
Role of Tetrabenazine for Huntington's Disease-Associated Chorea
Linda H. Poon et al.
ANNALS OF PHARMACOTHERAPY (2010)
A Randomized, Placebo-Controlled Trial of Latrepirdine in Huntington Disease
Karl Kieburtz et al.
ARCHIVES OF NEUROLOGY (2010)
Efficacy and Safety of the Dopaminergic Stabilizer Pridopidine (ACR16) in Patients With Huntington's Disease
Anders Lundin et al.
CLINICAL NEUROPHARMACOLOGY (2010)
Combating depression in Huntington's disease: effective antidepressive treatment with venlafaxine XR
Anna K. Holl et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2010)
Aripiprazole in the Treatment of Olanzapine-Resistant Psychotic and Motor Symptoms of Huntington's Disease
P. Oulis et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2010)
Cognition-Enhancing Properties of Dimebon in a Rat Novel Object Recognition Task Are Unlikely to Be Associated with Acetylcholinesterase Inhibition or N-Methyl-D-aspartate Receptor Antagonism
Marco Giorgetti et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Progress and Challenges in RNA Interference Therapy for Huntington Disease
Scott Q. Harper
ARCHIVES OF NEUROLOGY (2009)
Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators
Samuel Frank
BMC NEUROLOGY (2009)
Pathophysiology of Huntingtonʼs disease: from huntingtin functions to potential treatments
Emmanuel Roze et al.
CURRENT OPINION IN NEUROLOGY (2009)
Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins
Ferdinando Squitieri et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: Possible behavioural, biochemical and cellular alterations
Puneet Kumar et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Randomized Controlled Trial of Atomoxetine for Cognitive Dysfunction in Early Huntington Disease
Leigh J. Beglinger et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
Treatment of the Symptoms of Huntington's Disease: Preliminary Results Comparing Aripiprazole and Tetrabenazine
Livia Brusa et al.
MOVEMENT DISORDERS (2009)
Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration
F. Cicchetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Aripiprazole effects on psychosis and chorea in a patient with Huntington's disease
Wei-Chen Lin et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Randomized Controlled Trial of Ethyl-Eicosapentaenoic Acid in Huntington Disease
ARCHIVES OF NEUROLOGY (2008)
A study of chorea after tetrabenazine withdrawal in patients with Huntington disease
Samuel Frank et al.
CLINICAL NEUROPHARMACOLOGY (2008)
Reduction in Cerebral Atrophy Associated with Ethyl-eicosapentaenoic Acid Treatment in Patients with Huntington's Disease
B. K. Puri et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2008)
AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease
Nicholas R. Franich et al.
MOLECULAR THERAPY (2008)
Neuroprotective effects of riluzole in Huntington's disease
Ferdinando Squitieri et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Riluzole in Huntington's disease: A 3-year, randomized controlled study
G. Bernhard Landwehrmeyer et al.
ANNALS OF NEUROLOGY (2007)
Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients
A. Ciammola et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2007)
A systematic review of the treatment studies in Huntington's disease since 1990
Raphael M. Bonelli et al.
EXPERT OPINION ON PHARMACOTHERAPY (2007)
Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders
Christopher Kenney et al.
MOVEMENT DISORDERS (2007)
A pilot study of the clinical efficacy and safety of memantine for Huntington's disease
William G. Ondo et al.
PARKINSONISM & RELATED DISORDERS (2007)
Short-term effects of tetrabenazine on chorea associated with Huntington's disease
Christopher Kenney et al.
MOVEMENT DISORDERS (2007)
Two years' follow-up of rivastigmine treatment in Huntington disease
Marina de Tommaso et al.
CLINICAL NEUROPHARMACOLOGY (2007)
Huntington's disease: Pathological mechanisms and therapeutic strategies
Shilpa Ramaswamy et al.
CELL TRANSPLANTATION (2007)
Cholinergic neuronal defect without cell loss in Huntington's disease
Ruben Smith et al.
HUMAN MOLECULAR GENETICS (2006)
Effect of donepezil on motor and cognitive function in Huntington disease
E. Cubo et al.
NEUROLOGY (2006)
Effect of fetal neural transplants inpatients with Huntington's disease 6 years after surgery:: a long-term follow-up study
AC Bachoud-Lévi et al.
LANCET NEUROLOGY (2006)
Tetrabenazine as antichorea therapy in Huntington disease - A randomized controlled trial
FJ Marshall et al.
NEUROLOGY (2006)
Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2′dG
SM Hersch et al.
NEUROLOGY (2006)
Pharmacological management of Huntington's disease: An evidence-based review
Raphael M. Bonelli et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA
YL Wang et al.
NEUROSCIENCE RESEARCH (2005)
Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice
E Rodriguez-Lebron et al.
MOLECULAR THERAPY (2005)
Ethyl-EPA in Huntington disease - A double-blind, randomized, placebo-controlled trial
BK Puri et al.
NEUROLOGY (2005)
RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model
SQ Harper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
IV amantadine improves chorea in Huntington's disease: An acute randomized, controlled study
JM Heckmann et al.
NEUROLOGY (2004)
Effects of rivastigmine on motor and cognitive impairment in Huntington's disease
M de Tommaso et al.
MOVEMENT DISORDERS (2004)
Ziprasidone in Huntington's disease: the first case reports
RM Bonelli et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2003)
Creatine supplementation in Huntington's disease - A placebo-controlled pilot trial
P Verbessem et al.
NEUROLOGY (2003)
A Randomized trial of amantadine in Huntington disease
P O'Suilleabhain et al.
ARCHIVES OF NEUROLOGY (2003)
IV amantadine improves chorea in Huntington's disease - An acute randomized, controlled study
C Lucetti et al.
NEUROLOGY (2003)
Aripiprazole: A new atypical antipsychotic drug
TM Bowles et al.
ANNALS OF PHARMACOTHERAPY (2003)
Comparative study of action mechanisms of dimebon and memantine on AMPA- and NMDA-subtypes glutamate receptors in rat cerebral neurons
VV Grigor'ev et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2003)
Rivastigmine in the treatment of Huntington's disease
U Rot et al.
EUROPEAN JOURNAL OF NEUROLOGY (2002)
Olanzapine for Huntington's disease: An open label study
RM Bonelli et al.
CLINICAL NEUROPHARMACOLOGY (2002)
Quetiapine in Huntington's disease: a first case report
RM Bonelli et al.
JOURNAL OF NEUROLOGY (2002)
Olanzapine in Huntington's disease
D Paleacu et al.
ACTA NEUROLOGICA SCANDINAVICA (2002)
Bilateral human fetal striatal transplantation in Huntington's disease
RA Hauser et al.
NEUROLOGY (2002)
MRI and neuropsychological improvement in Huntington disease following ethyl-EPA treatment
BK Puri et al.
NEUROREPORT (2002)
A randomised, placebo-controlled, double blind study of treatment of Huntington's disease with unsaturated fatty acids
KS Vaddadi et al.
NEUROREPORT (2002)
Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington's disease
OA Andreassen et al.
NEUROBIOLOGY OF DISEASE (2001)
Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology
RC Petersen et al.
NEUROLOGY (2001)
Motor and cognitive improvements in patients with Huntington's disease after neural transplantation
A Bachoud-Lévi et al.
LANCET (2000)
Dimebon improves learning in animals with experimental Alzheimer's disease
NN Lermontova et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2000)
Share Paper
